Cet anticorps anti-LIV-1 (Ladiratuzumab Biosimilar) est un anticorps Humanized Chimeric détectant LIV-1 (Ladiratuzumab Biosimilar) dans . Adapté pour Humain.
N° du produit ABIN7597769
Aperçu rapide pour Recombinant LIV-1 (Ladiratuzumab Biosimilar) anticorps (ABIN7597769)
Antigène
LIV-1 (Ladiratuzumab Biosimilar)
Type d'anticorp
Recombinant Antibody
Reactivité
Humain
Hôte
Humanized
Clonalité
Chimeric
Conjugué
Cet anticorp LIV-1 (Ladiratuzumab Biosimilar) est non-conjugé
Application
Veuillez nous consulter SVP
Classe de qualité
Research Grade
Expression System
Mammalian cells
Fonction
Research Grade Ladiratuzumab Biosimilar Antibody
Specificité
SLC39A6, LIV1, Zrt- and Irt-like protein 6, Zinc transporter ZIP6, ZIP-6, Estrogen-regulated protein LIV-1, Solute carrier family 39 member 6, ZIP6
Purification
Protein A or G purified from cell culture supernatant.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Date de péremption
12 months
Antigène
LIV-1 (Ladiratuzumab Biosimilar)
Autre désignation
Ladiratuzumab Biosimilar
Classe de substances
Biosimilar
Sujet
SLC39A6, LIV1, Zrt- and Irt-like protein 6, Zinc transporter ZIP6, ZIP-6, Estrogen-regulated protein LIV-1, Solute carrier family 39 member 6, ZIP6